Physician profile
Eugene Ellison
NPI 1356341754
$1,119.72
in general payments reported to CMS, 2019-2025
17 companies · $71.54 in 2025
The $71.54 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $54.17 · 2021: $190 · 2022: $275 · 2023: $257 · 2025: $71.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $301.92 | 2019-2025 | Clareon, Argos |
| Aerie Pharmaceuticals, INC. | $180.55 | 2019-2021 | |
| Abbvie INC. | $140.54 | 2022-2025 | |
| Ocular Therapeutix, INC. | $102.78 | 2022-2023 | Dextenza |
| Biotissue Holdings INC. | $90.91 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $56.03 | 2019-2021 | |
| Oyster Point Pharma, INC. | $44.58 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $30.71 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.89 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $25.61 | 2021 | |
| Rayner Intraocular Lenses Limited | $19.75 | 2023 | Rayone Spheric, Omidria, Rayone Emv |
| Rxsight INC | $18.80 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $18.55 | 2025 | Xdemvy |
| Shire North American Group INC | $18.31 | 2019 | |
| Omeros Corporation | $16.60 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $16.51 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Ellison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.